Neurotensin contributes to cholestatic liver disease potentially modulating matrix metalloprotease-7

Int J Biochem Cell Biol. 2024 May:170:106567. doi: 10.1016/j.biocel.2024.106567. Epub 2024 Mar 24.

Abstract

The diagnosis and treatment of biliary atresia pose challenges due to the absence of reliable biomarkers and limited understanding of its etiology. The plasma and liver of patients with biliary atresia exhibit elevated levels of neurotensin. To investigate the specific role of neurotensin in the progression of biliary atresia, the patient's liver pathological section was employed. Biliary organoids, cultured biliary cells, and a mouse model were employed to elucidate both the potential diagnostic significance of neurotensin and its underlying mechanistic pathway. In patients' blood, the levels of neurotensin were positively correlated with matrix metalloprotease-7, interleukin-8, and liver function enzymes. Neurotensin and neurotensin receptors were mainly expressed in the intrahepatic biliary cells and were stimulated by bile acids. Neurotensin suppressed the growth and increased expression of matrix metalloprotease-7 in biliary organoids. Neurotensin inhibited mitochondrial respiration, oxidative phosphorylation, and attenuated the activation of calmodulin-dependent kinase kinase 2-adenosine monophosphate-activated protein kinase (CaMKK2-AMPK) signaling in cultured biliary cells. The stimulation of neurotensin in mice and cultured cholangiocytes resulted in the upregulation of matrix metalloprotease-7 expression through binding to its receptors, namely neurotensin receptors 1/3, thereby attenuating the activation of the CaMKK2-AMPK pathway. In conclusion, these findings revealed the changes of neurotensin in patients with cholestatic liver disease and its mechanism in the progression of the disease, providing a new understanding of the complex mechanism of hepatobiliary injury in children with biliary atresia.

Keywords: Biliary atresia; CaMKK2; Liver diseases; MMP7; Neurotensin.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Biliary Atresia* / metabolism
  • Biliary Atresia* / pathology
  • Child
  • Humans
  • Liver / metabolism
  • Liver Diseases* / metabolism
  • Metalloproteases / metabolism
  • Mice
  • Neurotensin / metabolism
  • Receptors, Neurotensin / metabolism

Substances

  • AMP-Activated Protein Kinases
  • Metalloproteases
  • Neurotensin
  • Receptors, Neurotensin
  • MMP7 protein, human